Literature DB >> 6375284

Effects of verapamil in hypertensive patients.

P W de Leeuw, W H Birkenhäger.   

Abstract

In fifteen patients with uncomplicated essential hypertension verapamil reduced systolic as well as diastolic blood pressure by virtue of a decrease in total peripheral vascular resistance. Renal vascular resistance also fell, but renal perfusion was well maintained. Although levels of renin and angiotensin II remained unchanged, aldosterone levels fell significantly. Noradrenaline levels rose slightly, but changes were not significant. On the other hand adrenaline was significantly reduced. Renal sodium excretion was markedly enhanced, perhaps secondary to aldosterone suppression. Despite sodium loss, plasma volume increased suggesting that verapamil not only lowers arterial but also venous resistance.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375284     DOI: 10.1111/j.0954-6820.1984.tb08686.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  4 in total

Review 1.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 2.  Effects of calcium antagonists on the hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

Review 3.  Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.

Authors:  A Fitton; P Benfield
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

4.  Effect of verapamil on renal plasma flow, glomerular filtration rate and plasma angiotensin II, aldosterone and arginine vasopressin in essential hypertension.

Authors:  S S Sørensen; O O Thomsen; H Danielsen; E B Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.